Core Insights - Evolent Health and American Oncology Network (AON) have formed a partnership to enhance cancer care quality and affordability without the need for prior authorization [1][2][5] Partnership Objectives - The partnership aims to improve clinical decision-making through quality-focused interventions and an innovative data analytics platform [2][6] - Providers demonstrating adherence to quality will receive "gold-carding," eliminating the need for prior authorization for most tests and treatments [2][6] Key Components of the Program - **Quality Initiatives**: Focus on high-impact opportunities to enhance quality and affordability across the care continuum, utilizing provider education and automated reminders [6] - **AI-Driven Clinical Insights**: The MiBA platform will provide evidence-based insights and personalized treatment plans by analyzing real-time data [6] - **Payment Innovation**: Development of a payment model that rewards high-quality care, moving away from traditional fee-for-service models [6] - **Eliminating Prior Authorization**: High-quality treatment pathways will allow providers to bypass prior authorization, expediting treatment and reducing administrative burdens [6] - **Care Navigation**: AON patients will benefit from Evolent's cancer care navigation program, enhancing support throughout their treatment journey [6] Company Backgrounds - **Evolent Health**: Specializes in improving health outcomes for complex conditions, recognized for its innovative healthcare solutions [5][7] - **American Oncology Network (AON)**: An alliance of physicians focused on community oncology, promoting value-based care and health equity [7]

Core Insights - The Oncology Institute, Inc. (TOI) has been selected to present an abstract at the ASCO Annual Meeting, highlighting the cost savings and reduced hospitalizations associated with its High-Value Cancer Care (HVCC) model [1][2] - The HVCC model has demonstrated over 50% reductions in Emergency Department utilization and hospitalizations, along with cost savings exceeding $12,000 per patient enrolled [2][5] Company Overview - Founded in 2007, TOI specializes in value-based cancer care, serving over 1.8 million patients with a team of over 120 clinicians and more than 700 staff across 70 clinic locations [4] - TOI's approach includes evidence-based cancer care, clinical trials, and transfusions, aiming to improve oncology care in community settings [4] Clinical Outcomes - Recent data indicates a 53% reduction in Emergency Department use, a 68% decrease in hospitalizations, and a 75% lower odds of death in acute care facilities for patients enrolled in the HVCC model [5] - The total cost of care is lowered by $12,000 per enrolled patient, further validating the effectiveness of TOI's care model [5]